| abstract |
The invention concerns the genome sequence and nucleotide sequences of Listeria monocytogenes EGD-e. The invention also concerns polypeptides of said organism, in particular surface or cell envelope polypeptides, or polypeptides involved in the different metabolism cycles, in particular vitamin B12 biosynthesis. The invention further concerns uses of said sequences, and various tools enabling identification of L. monocytogenes or associated species. Finally, the invention concerns modified L. monocytogenes strains, and pharmaceutical or vaccine compositions using the inventive sequences. |